Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression

Kidney International

Volumn 50, Issue 2, 1996, Pages 526-537

  Yilmaz, Serdar ^b   Koskinen, Petri K ^b   Kallio, Erkki ^b   Bruggeman, Cathrien A ^b   Häyry, Pekka J ^b   Lemström, Karl B ^a  

^a Transplantation Laboratory   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; INTERCELLULAR ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; HISTOLOGY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS PLAQUE;

EID: 0029836039     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.345     Document Type: Article

References (58)

1. SCHWEITZER EJ, MATAS AJ, GILLINGHAM KJ: Causes of renal allograft loss. Ann Surg 214:679-686, 1991
2. HANCOCK WH, WHITLEY WD, TULLIUS SG, HEEMAN UW, WASOWSKA B, BALDWIN WM III, TILNEY NL: Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 56:643-650, 1993
3. LINDHOLM A, OHLMAN S, ALBRECHTSEN D, TUFVESON G, PERSSON H, PERSSON NH: The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 56:307-315, 1993
4. YILMAZ S, HÄYRY P: The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation 56:1153-1156, 1993
5. OPELTZ G, FOR THE COLLABORATIVE TRANSPLANT STUDY: Strength of HLA-A, HLA-B, HLA-DR mismatches in relation to short- and long-term kidney graft survival. Transplant Int 5:S621-S624, 1992
6. ALMOND PS, MATAS A, GILLINGHAM K, DUNN DL, PAYNE WD, GORES P, GRUESSNER R, NAJARIAN JS: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55:752-756, 1993
7. ISONIEMI H, NURMINEN M, TIKKANEN MJ, VON WILLEBRAND E, KROGERUS L, AHONEN J, EKLUND B, HÖCKERSTEDT K, SALMELA K, HÄYRY P: Risk factors predicting chronic rejection of renal allgrafts. Transplantation 57:68-72, 1994
8. cre). Kidney Int 48:251-258, 1995
9. RUBIN RH, TOLKOFF-RUBIN NE, OLIVER D, ROTA TR, HAMILTON J, BETTS RF, PASS RF, HILLIS W, SZMUNESS W, FARRELL ML, HIRSCH MS: Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 40:243-249, 1985
10. REINKE P, FIETZE E, ODE-HAKIM S, PRÖSCH S, LIPPERT J, EWERT R, VOLK H-D: Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 344:1737-1738, 1994
11. YILMAZ S, TASKINEN E, PAAVONEN T, MENNANDER A, HÄYRY P: Chronic rejection of rat renal allograft. I. Histological differentiation between chronic rejection and cyclosporine nephrotoxicity. Transplant Int 5: 85-95, 1992
12. FISHER B, LEE S: Microvascular surgical techniques in research, with special reference to renal transplantation in the rat. Surgery 58:904-913, 1965
13. PAUL LC, HÄYRY P, FOEGH M, DENNIS MJ, MIHATSCH MJ, LARSSON E, FELLSTRÖM B: Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: Joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs. Transplant Proc 25:2022, 1993
14. BRUGGEMAN CA, MEIJER H, DORMANS PHJ, DEBIE WMH, GRAULS GELM, VAN BOVEN CPA: Isolation of a cytomegalovirus-like agent from wild rats. Arch Virol 73:231-241, 1982
15. BRUGGEMAN CA, DEBIE WMH, GRAULS G, MAJOOR G, VAN BOVEN CPA: Infection of laboratory rats with a new cytomegalo-like virus. Arch Virol 76:188-199, 1983
16. ARVIN AM: Cytomegaloviruses, in Laboratory Diagnosis of Viral Infections, edited by LENNETTE EH, New York, Marcel Dekker, 506 pp
17. WENTWORTH B, FRENCH L: Plaque assay of CMV strains of human origin. Proc Soc Exp Biol Med 135:253-258, 1970
18. BAHN AK: Immunoperoxidase, in Diagnostic Immunopathology, edited by COLVIN RB, BHAN AK, MCCLUSKEY RT, New York, Raven Press, 1988, pp 437-452
19. BRUNING JH, DEBIE WHM, DORMANS PHJ, MEYER H, BRUGGEMAN CA: The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens. Arch Virol 94:55-70, 1987
20. STALS FS, BOSMAN F, VAN BOVEN CPA, BRUGGEMAN CA: An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Arch Virol 114:91-107, 1990
21. PIPKIN FB: Medical Statistics Made Easy, Edinburgh, Churchill Livingstone, 138 pp
22. LEMSTRÖM K, BRUNING JH, BRUGGEMAN CA, LAUTENSCHLAGER IT, HAYRY P: Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat cardiac allografts. J Clin Invest 92:549-559, 1993
23. BRUNING JH, BRUGGEMAN CA, VAN BOVEN CPA, VAN BREDA VRIESMAN PJC: Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model. Transplantation 41:695-698, 1986
24. BRUGGEMAN CA: Reactivation of latent CMV in the rat, Transplant Proc 23:22-24, 1991
25. ISONIEMI H, TASKINEN E, HÄYRY P: Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 58:1195-1198, 1994
26. VON WILLEBRAND E, PETTERSSON E, AHONEN J, HÄYRY P: CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 42:364-367, 1986
27. POUTEIL-NOBLE C, ECOCHARD R, LANDRIVON G, DONIA-MAGED A, TARDY J-C, BOSSHARD S, COLON S, BETUEL H, AYMARD M, TOURAINE J-L: Cytomegalovirus infection: An etiological factor for rejection? Transplantation 55:851-857, 1993
28. PAYNE JE, FIALA M, SPENCER M, CHATTERJHE SN, BERNE TV: Cytomegalovirus antigen-antibody complexes in biopsy specimens in renal allograft rejection. Surg Forum 25:273-281, 1974
29. GRATTAN MT, MORENO-GABRAL CE, STARNES VA, OYER PE, STINSON EB, SHUMWAY NE: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561-3566, 1989
30. GRADY JG, AXEXANDER GJM, SUTHERLAND S, DONALDSON PT, HARVEY F, PORTMANN B, CALNE RY, WILLIAMS R: Cytomegalovirus infection and donor/recipient HLA antigens: Interdependent cofactors in pathogenesis of vanishing bileduct syndrome after liver transplantation. Lancet 2:302-304, 1988
31. LEMSTRÖM KB, BRUNING JH, BRUGGEMAN CA, LAUTENSCHLAGER IT, HÄYRY PJ: Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirusinfected rat aortic allografts and induces early latency of viral infection. Am J Pathol 144:1334-1347, 1994
32. RICHARDSON WP, COLVIN RB, CHEESEMAN SH, TOLKOFF-RUBIN NE, HERRIN JT, COSIMI AB, COLLINS AB, HIRSCH MS, MCCLUSKEY RT, RUSSELL PS, RUBIN RH: Glomerulopathy associated with cytomegalovirus viremia in renal alllografts. N Engl J Med 305:57-63, 1981
33. USTINOV JA, LOGINOV RJ, MATTILA PM, NIEMINEN VK, SUNI JI, HÄYRY PJ, LAUTENSCHLAGER IT: Cytomegalovirus infection of human kidney cells in vitro. Kidney Int 40:954-960, 1991
34. HEIEREN MH, VAN DER WOUDE FJ, BALFOUR HH: Cytomegalovirus replicates efficiently in human kidney mesangial cells. Proc Natl Acad Sci USA 85:1642-1646, 1988
35. HEIEREN MH, KIM Y, BALFOUR HH: Human cytomegalovirus infection of kidney glomerular visceral epithelial and tubular epithelial cells in culture. Transplantation 46:426-432, 1988
36. Ho DD, ROTA TR, ANDREWS CA, HIRSCH MS: Replication of human cytomegalovirus in endothelial cells. J Infect Dis 150:956-957, 1984
37. SEDMAK DD, ROBERTS WH, STEPHENS RE, BUESCHING WJ, MORGAN LA, DAVIS DH, WALDMAN WJ: Inability of cytomegalovirus infection of human cultured endothelial cells to induce HLA class II antigen expression. Transplantation 49:458-462, 1990
38. SMILEY ML, MAR E-C, HUANG E-S: Cytomegalovirus infection and viral-induced transformation of human endothelial cells. J Med Virol 25:213-226, 1988
39. PAYTON D, THORNER P, EDDY A, YEGER H, BAUMEL R: Demonstration by light microscopy of cytomegalovirus on a renal biopsy of a renal allograft recipient. Nephron 47:205-208, 1987
40. MACASAET FF, HOLLEY KE, SMOTH TF, KEYS TF: Cytomegalovirus studies of autopsy tissue. II Incidence of inclusion bodies and related pathological data AJCP 63:859-865, 1975
41. MYERSON D, HACKMAN RC, NELSON JA, WARD DC, MCDOUGALL JK: Widespread presence of histologically occult cytomegalovirus, Hum Pathol 15:430-439, 1984
42. CAPPEL R, HESTERMANS O, TOUSSAINT CH, VEREERSTRAETEN P, VAN BEERS D, DE BRAEKELEER J, SHOUTENS E: Cytomegalovirus infection and graft survival in renal graft recipients. Arch Virol 56:149-154, 1978
43. WEIMAR W, BALK AHM, METSELAAR HJ, MOCHTAR B, ROTHBARTH PH: On the relation between cytomegalovirus infection and rejection after heart transplantation. Transplantation 52:162-164, 1991
44. KELLER RR, PEITCHEL JN, GOLDMAN JN, GOLDMAN M: An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts. J Immunol 116:772-777, 1976
45. MACGREGOR RR, FRIEDMAN HM, MACARAK EJ, KEFALIDES NA: Virus infection of endothelial cells increases granulocyte adherence. J Clin Invest 65:1469-1477, 1980
46. FUJINAMI RS, NELSON JA, WALKER L, OLDSTONE MB: Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR β-chain: A means for graft rejection and immunosuppression. J Virol 62:100-105, 1988
47. USTINOV J, LOGINOV R, BRUGGEMAN CA, VAN DER MEIDE P, HÄYRY P, LAUTENSCHLAGER I: Cytomegalovirus induces class II expression in rat heart endothelial cells, J Heart Lung Transplant 12:644-651, 1993
48. WALDMAN WJ, KNIGHT DA, ADAMS PW, OROSZ CG, SEDMAK DD: In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells. Transplantation 56:1504-1512, 1993
49. BECK S, BARRELL BG: Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331:269-272, 1988
50. VAN DORP WT, JONGES E, BRUGGEMAN CA, DAHA MR, VAN Es LA, VAN DER WOUDE FJ: Direct induction of MHC class I, hut not class II, expression on endothelial cells by cytomegalovirus infection. Transplantation 48:469-472, 1989
51. HOSENPUD JD, CHOU S, WAGNER CR: Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Transplantation 5:896-903, 1991
52. KOSKINEN PK: The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts. Transplantation 56:1103-1108, 1993
53. IWAMOTO GK, MONICK MM, CLARK BD, AURON PE, STINSKI MF, HUNNINGHAKE GW: Modulation of interleukin 1-beta gene expression by the immediate early genes of human cytomegalovirus. J Clin Invest 85:1853-1857, 1990
54. SISSON JGP, BORYSIEWICZ LK, ROGERS B, SCOTT D: Cytomegalovirus - Its cellular immunology and biology, Immunol Today 7:57-61, 1986
55. SMITH KA: Interleukin-2: Inception, impact and implications. Science 240:1169-1176, 1988
56. GEIST LJ, MONICK MM, STINSKI MF, HUNNINGHAKE GW: The immediate early genes of human cytomegalovirus upregulate expression of interleukin-2 and interleukin-2 receptors genes. Am J Respir Cell Mol Biol 5:292-296, 1991
57. GEIST LJ, MONICK MM, STINSKI MF, HUNNINGHAKE GW: Cytomegalovirus immediate early genes prevent the inhibitory effect of cyclosporine A on interleukin 2 gene transcription. J Clin Invest 90:2136-2140, 1990
58. LEMSTRÖM KB, AHO PT, BRUGGEMAN CA, HÄYRY PJ: Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis. Arteriosclerosis Thromb 14:2043-2052, 1994